Ahn K et al. |
Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. |
2008 |
Chem. Rev. |
pmid:18429637
|
Gurney AM et al. |
Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle cells. |
2003 |
Circ. Res. |
pmid:14551239
|
Fernandez-Patron C et al. |
Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. |
2000 |
Circ. Res. |
pmid:11029402
|
Bátkai S et al. |
Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. |
2004 |
Circulation |
pmid:15451779
|
Hong Z et al. |
Role of store-operated calcium channels and calcium sensitization in normoxic contraction of the ductus arteriosus. |
2006 |
Circulation |
pmid:16982938
|
Alenmyr L et al. |
TRPV1 and TRPA1 stimulation induces MUC5B secretion in the human nasal airway in vivo. |
2011 |
Clin Physiol Funct Imaging |
pmid:21981454
|
Cui N et al. |
Restored Plasma Anandamide and Endometrial Expression of Fatty Acid Amide Hydrolase in Women With Polycystic Ovary Syndrome by the Combination Use of Diane-35 and Metformin. |
2017 |
Clin Ther |
pmid:28291580
|
Schroeder C et al. |
Circulating endocannabinoid concentrations during orthostatic stress. |
2009 |
Clin. Auton. Res. |
pmid:19756829
|
Vogeser M et al. |
Release of anandamide from blood cells. |
2006 |
Clin. Chem. Lab. Med. |
pmid:16599845
|
Busch L et al. |
Effects of castration on cannabinoid cb receptor expression and on the biological actions of cannabinoid in the parotid gland. |
2006 |
Clin. Exp. Pharmacol. Physiol. |
pmid:16487271
|
Ruginsk SG et al. |
Anandamide modulates the neuroendocrine responses induced by extracellular volume expansion. |
2013 |
Clin. Exp. Pharmacol. Physiol. |
pmid:23875874
|
Barun S et al. |
Effects of cannabinoid receptor activation on rabbit bisected vas deferens strips. |
2005 |
Clin. Exp. Pharmacol. Physiol. |
pmid:16173925
|
Mitchell VA et al. |
Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models. |
2007 |
Clin. Exp. Pharmacol. Physiol. |
pmid:17880375
|
Tuboly G et al. |
Antinociceptive interactions between anandamide and endomorphin-1 at the spinal level. |
2009 |
Clin. Exp. Pharmacol. Physiol. |
pmid:19018802
|
Dollery C |
Investigative clinical pharmacology. |
2011 |
Clin. Pharmacol. Ther. |
pmid:21862965
|
Zoerner AA et al. |
Allergen challenge increases anandamide in bronchoalveolar fluid of patients with allergic asthma. |
2011 |
Clin. Pharmacol. Ther. |
pmid:21716266
|
Guindon J and Hohmann AG |
The endocannabinoid system and pain. |
2009 |
CNS Neurol Disord Drug Targets |
pmid:19839937
|
Lambert RC et al. |
Modulation of neuronal T-type calcium channels. |
2006 |
CNS Neurol Disord Drug Targets |
pmid:17168746
|
Khanna IK and Alexander CW |
Fatty acid amide hydrolase inhibitors--progress and potential. |
2011 |
CNS Neurol Disord Drug Targets |
pmid:21631410
|
GarcÃa-GarcÃa F et al. |
Sleep-inducing factors. |
2009 |
CNS Neurol Disord Drug Targets |
pmid:19689305
|
Nilsson O et al. |
Cannabinoid CB1 receptor activation does not prevent the toxicity of glutamate towards embryonic chick telencephalon primary cultures. |
2003 |
Comp. Biochem. Physiol. C Toxicol. Pharmacol. |
pmid:14659458
|
Després JP |
The endocannabinoid system: a new target for the regulation of energy balance and metabolism. |
2007 |
Crit Pathw Cardiol |
pmid:17667864
|
Kadoi Y et al. |
Cannabinoid antagonist AM 281 reduces mortality rate and neurologic dysfunction after cecal ligation and puncture in rats. |
2005 |
Crit. Care Med. |
pmid:16276190
|
Panagis G et al. |
Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties. |
2008 |
Curr Drug Abuse Rev |
pmid:19630731
|
Ligresti A et al. |
Endocannabinoid metabolic pathways and enzymes. |
2005 |
Curr Drug Targets CNS Neurol Disord |
pmid:16375679
|
Maccarrone M et al. |
Endocannabinoid degradation, endotoxic shock and inflammation. |
2002 |
Curr Drug Targets Inflamm Allergy |
pmid:14561206
|
Guindon J and Beaulieu P |
The role of the endogenous cannabinoid system in peripheral analgesia. |
2009 |
Curr Mol Pharmacol |
pmid:20021453
|
Battista N et al. |
Endocannabinoids and their involvement in the neurovascular system. |
2004 |
Curr Neurovasc Res |
pmid:16185189
|
Cravatt BF and Lichtman AH |
Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. |
2003 |
Curr Opin Chem Biol |
pmid:12941421
|
Rice AS |
Cannabinoids and pain. |
2001 |
Curr Opin Investig Drugs |
pmid:11575713
|
Izzo AA et al. |
The gastrointestinal pharmacology of cannabinoids. |
2001 |
Curr Opin Pharmacol |
pmid:11757815
|
Pate DW et al. |
Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits. |
1995 |
Curr. Eye Res. |
pmid:8529418
|
Di Marzo V et al. |
Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids. |
1999 |
Curr. Med. Chem. |
pmid:10469888
|
Reggio PH |
Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown. |
2010 |
Curr. Med. Chem. |
pmid:20166921
|
Di Marzo V and De Petrocellis L |
Endocannabinoids as regulators of transient receptor potential (TRP) channels: A further opportunity to develop new endocannabinoid-based therapeutic drugs. |
2010 |
Curr. Med. Chem. |
pmid:20166923
|
Ashton JC et al. |
Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists. |
2008 |
Curr. Med. Chem. |
pmid:18537620
|
Dainese E et al. |
Modulation of the endocannabinoid system by lipid rafts. |
2007 |
Curr. Med. Chem. |
pmid:17979719
|
Kreitzer AC and Regehr WG |
Retrograde signaling by endocannabinoids. |
2002 |
Curr. Opin. Neurobiol. |
pmid:12049940
|
Ohno-Shosaku T and Kano M |
Endocannabinoid-mediated retrograde modulation of synaptic transmission. |
2014 |
Curr. Opin. Neurobiol. |
pmid:24747340
|
Di Marzo V et al. |
Endovanilloid signaling in pain. |
2002 |
Curr. Opin. Neurobiol. |
pmid:12139983
|
Bisogno T et al. |
Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications. |
2002 |
Curr. Pharm. Des. |
pmid:11945157
|
Leweke FM |
Anandamide dysfunction in prodromal and established psychosis. |
2012 |
Curr. Pharm. Des. |
pmid:22716147
|
Di Marzo T et al. |
Endocannabinoids: new targets for drug development. |
2000 |
Curr. Pharm. Des. |
pmid:10903398
|
Palmer SL et al. |
Natural and synthetic endocannabinoids and their structure-activity relationships. |
2000 |
Curr. Pharm. Des. |
pmid:10903399
|
Fowler CJ |
"The tools of the trade"--an overview of the pharmacology of the endocannabinoid system. |
2008 |
Curr. Pharm. Des. |
pmid:18781976
|
Harvey BS et al. |
Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability. |
2013 |
Cytokine |
pmid:23706402
|
Harvey BS et al. |
Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model. |
2014 |
Cytokine |
pmid:24238999
|
Levin M and Mercola M |
Gap junctions are involved in the early generation of left-right asymmetry. |
1998 |
Dev. Biol. |
pmid:9806775
|
Levin M and Mercola M |
Expression of connexin 30 in Xenopus embryos and its involvement in hatching gland function. |
2000 |
Dev. Dyn. |
pmid:10974676
|
Buznikov GA et al. |
A putative 'pre-nervous' endocannabinoid system in early echinoderm development. |
2010 |
Dev. Neurosci. |
pmid:19907129
|